-
PREVALENCE OF CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME AMONG OLDER WOMEN WITH BREAST CANCER IN THE 2011-2021 SEER-MEDICARE DATA
Mar 18, 2026, 21:38 PM -
GENE THERAPY DEVELOPMENT PROGRAMS ARE BOTH GROWING AND EVOLVING IN THE FACE OF COMMERCIAL HEADWINDS
Mar 18, 2026, 21:38 PM -
INTEGRATION OF GENERATIVE ARTIFICIAL INTELLIGENCE INTO THE DEVELOPMENT OF STATISTICAL ANALYSIS PLANS FOR PATIENT-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
EVALUATING THE PERFORMANCE OF A GENERATIVE ARTIFICIAL INTELLIGENCE CHATBOT FOR ASSESSING SYSTEMATIC LITERATURE REVIEWS USING THE PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES 2020 CHECKLIST
Mar 18, 2026, 21:38 PM -
MEDICATION-TAKING BEHAVIOUR IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD): A QUALITATIVE ANALYSIS OF SOCIAL MEDIA DATA
Mar 18, 2026, 21:38 PM -
INCREASING UTILITY OF INTEGRATED REAL-WORLD EVIDENCE THROUGHOUT THE PRODUCT LIFECYCLE TO SUPPORT HEALTHCARE REIMBURSEMENT
Mar 18, 2026, 21:38 PM -
ROLE OF REAL-WORLD EVIDENCE IN SUPPORTING AND VALIDATING CROSSOVER ADJUSTMENTS OF OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SYSTEMATIC LITERATURE REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS OF TREATMENTS FOR SELECTED TUMORS
Mar 18, 2026, 21:38 PM -
A DECISION TREE ESTIMATING TOTAL COST OF CARE USING EXPOSURE-ADJUSTED DISCONTINUATION: CAPSAICIN 8% VERSUS ORAL TREATMENTS FOR PAINFUL DIABETIC NEUROPATHY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST OF HEALTHCARE IN PATIENTS NEWLY DIAGNOSED WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS
Mar 18, 2026, 21:38 PM -
ESTIMATING THE COST OF ORPHAN DRUG TREATMENT FROM THE PERSPECTIVE OF MEXICO'S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
EFFECT OF ANTIHYPERTENSIVE USE ON FALL RISK
Mar 18, 2026, 21:38 PM -
DIGITAL BIOMARKERS OF SLEEP, STRESS, AND MENTAL HEALTH IN YOUTH: A SCOPING REVIEW OF OURA RING-BASED EVIDENCE
Mar 18, 2026, 21:38 PM -
DIGITAL HEALTH FOR HYPERTENSION IN RURAL NORTHERN NIGERIA: REAL-WORLD PATIENT-CENTERED AND ECONOMIC OUTCOMES FROM A MIXED-METHODS STUDY
Mar 18, 2026, 21:38 PM -
SAFETY OF SEPIAPTERIN AND PEGVALIASE FOR THE TREATMENT OF PHENYLKETONURIA (PKU): A SIMULATED TREATMENT COMPARISON (STC)
Mar 18, 2026, 21:38 PM -
INCORPORATING REAL-WORLD EVIDENCE (RWE) USING A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) AUGMENTS TRADITIONAL SLRS: CASE STUDY IN NON-SMALL-CELL LUNG CANCER (NSCLC)
Mar 18, 2026, 21:38 PM -
UNCOVERING EVIDENCE GAPS IN THE CLINICAL, ECONOMIC, AND HUMANISTIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY: A COMPREHENSIVE LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
NATIONWIDE COVID-19 TESTING PATTERNS AND DISPARITIES IN POSITIVITY AND ANTIVIRAL TREATMENT IN A U.S. RETAIL PHARMACY CHAIN, SEPTEMBER-DECEMBER 2025
Mar 18, 2026, 21:38 PM -
HOW REPRESENTATIVE ARE LICENSABLE DATASETS COMPARED TO THEIR SOURCE POPULATION
Mar 18, 2026, 21:38 PM -
INFLUENCING FACTORS ON THE APPROVAL LAG FOR INNOVATIVE DRUGS IN CHINA
Mar 18, 2026, 21:38 PM -
DISABILITY AND ADHERENCE TO GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS AMONG U.S. ADULTS WITH DIABETES: EVIDENCE FROM THE MEDICAL EXPENDITURE PANEL SURVEY
Mar 18, 2026, 21:38 PM
